417 related articles for article (PubMed ID: 19037908)
1. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
Singh R; Kapoor R; Srivastava A; Mittal RD
Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
[TBL] [Abstract][Full Text] [Related]
2. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.
Omrani MD; Mokhtari MR; Tagizadae A; Bagheri M; Ahmad-Poor P
Iran J Immunol; 2008 Dec; 5(4):201-6. PubMed ID: 19098363
[TBL] [Abstract][Full Text] [Related]
3. Allograft renal rejection and chemokine polymorphism.
Gorgi Y; Sfar I; Jendoubi-Ayed S; Makhlouf M; Rhomdhane TB; Bardi R; Aouadi H; Abdallah TB; Abderrahim E; Ayed K
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):18-23. PubMed ID: 21196609
[TBL] [Abstract][Full Text] [Related]
4. The effect of chemokine receptor gene polymorphisms (CCR2V64I, CCR5-59029G>A and CCR5Δ32) on renal allograft survival in Pakistani transplant patients.
Firasat S; Raza A; Abid A; Aziz T; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Khaliq S
Gene; 2012 Dec; 511(2):314-9. PubMed ID: 23041556
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor 2-V64I and chemokine receptor 5-Delta32 polymorphisms and clinical risk factors of delayed graft function and acute rejection in kidney transplantation.
Azmandian J; Mandegary A; Saber A; Torshabi M; Etminan A; Ebadzadeh MR; Fazeli F; Soleymani S; Taghipour A; Karimi MA
Iran J Kidney Dis; 2012 Jan; 6(1):56-62. PubMed ID: 22218121
[TBL] [Abstract][Full Text] [Related]
8. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival.
Yigit B; Bozkurt N; Berber I; Titiz I; Isbir T
Cell Biochem Funct; 2007; 25(4):423-6. PubMed ID: 16598837
[TBL] [Abstract][Full Text] [Related]
10. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.
Soto-Sánchez J; Santos-Juanes J; Coto-Segura P; Coto E; Díaz M; Rodríguez I; Alvarez V
Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665
[TBL] [Abstract][Full Text] [Related]
12. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
13. Donor CCR5 Delta32 polymorphism and outcome following cardiac transplantation.
Fildes JE; Walker AH; Howlett R; Bittar MN; Hutchinson IV; Leonard CT; Yonan N
Transplant Proc; 2005 Jun; 37(5):2247-9. PubMed ID: 15964389
[TBL] [Abstract][Full Text] [Related]
14. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
[TBL] [Abstract][Full Text] [Related]
15. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
16. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
17. Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients.
Singh R; Manchanda PK; Kesarwani P; Srivastava A; Mittal RD
Clin Transplant; 2009; 23(4):490-8. PubMed ID: 19486347
[TBL] [Abstract][Full Text] [Related]
18. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
